These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37630490)

  • 1.
    Rebai Y; Wagner L; Gnaien M; Hammer ML; Kapitan M; Niemiec MJ; Mami W; Mosbah A; Messadi E; Mardassi H; Vylkova S; Jacobsen ID; Znaidi S
    Microorganisms; 2023 Jul; 11(8):. PubMed ID: 37630490
    [No Abstract]   [Full Text] [Related]  

  • 2. Probiotic Escherichia coli Nissle 1917 reduces growth, Shiga toxin expression, release and thus cytotoxicity of enterohemorrhagic Escherichia coli.
    Mohsin M; Guenther S; Schierack P; Tedin K; Wieler LH
    Int J Med Microbiol; 2015 Jan; 305(1):20-6. PubMed ID: 25465158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Escherichia coli Nissle 1917 Enhances Innate and Adaptive Immune Responses in a Ciprofloxacin-Treated Defined-Microbiota Piglet Model of Human Rotavirus Infection.
    Michael H; Paim FC; Langel SN; Miyazaki A; Fischer DD; Chepngeno J; Amimo J; Deblais L; Rajashekara G; Saif LJ; Vlasova AN
    mSphere; 2021 Mar; 6(2):. PubMed ID: 33789939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of F1C fimbriae, flagella, and secreted bacterial components in the inhibitory effect of probiotic Escherichia coli Nissle 1917 on atypical enteropathogenic E. coli infection.
    Kleta S; Nordhoff M; Tedin K; Wieler LH; Kolenda R; Oswald S; Oelschlaeger TA; Bleiss W; Schierack P
    Infect Immun; 2014 May; 82(5):1801-12. PubMed ID: 24549324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonistic effects of probiotic Escherichia coli Nissle 1917 on EHEC strains of serotype O104:H4 and O157:H7.
    Rund SA; Rohde H; Sonnenborn U; Oelschlaeger TA
    Int J Med Microbiol; 2013 Jan; 303(1):1-8. PubMed ID: 23312798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-8, CXCL1, and MicroRNA miR-146a Responses to Probiotic Escherichia coli Nissle 1917 and Enteropathogenic E. coli in Human Intestinal Epithelial T84 and Monocytic THP-1 Cells after Apical or Basolateral Infection.
    Sabharwal H; Cichon C; Ölschläger TA; Sonnenborn U; Schmidt MA
    Infect Immun; 2016 Sep; 84(9):2482-92. PubMed ID: 27297392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The administration of Escherichia coli Nissle 1917 ameliorates irinotecan-induced intestinal barrier dysfunction and gut microbial dysbiosis in mice.
    Wang Y; Sun L; Chen S; Guo S; Yue T; Hou Q; Feng M; Xu H; Liu Y; Wang P; Pan Y
    Life Sci; 2019 Aug; 231():116529. PubMed ID: 31173781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The secreted autotransporter toxin (Sat) does not act as a virulence factor in the probiotic Escherichia coli strain Nissle 1917.
    Toloza L; Giménez R; Fábrega MJ; Alvarez CS; Aguilera L; Cañas MA; Martín-Venegas R; Badia J; Baldomà L
    BMC Microbiol; 2015 Oct; 15():250. PubMed ID: 26518156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. K5 Capsule and Lipopolysaccharide Are Important in Resistance to T4 Phage Attack in Probiotic
    Soundararajan M; von Bünau R; Oelschlaeger TA
    Front Microbiol; 2019; 10():2783. PubMed ID: 31849915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Probiotic E. coli Nissle 1917 Supplementation on the Growth Performance, Immune Responses, Intestinal Morphology, and Gut Microbes of Campylobacter jejuni Infected Chickens.
    Helmy YA; Closs G; Jung K; Kathayat D; Vlasova A; Rajashekara G
    Infect Immun; 2022 Oct; 90(10):e0033722. PubMed ID: 36135600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probiotic Escherichia coli Nissle 1917 propelled micro-robot with pH sensitivity for hypoxia targeted intestinal tumor therapy.
    Wang T; Yin Q; Huang HY; Wang Z; Song H; Luo X
    Colloids Surf B Biointerfaces; 2023 May; 225():113277. PubMed ID: 36996630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nattokinase enhances the preventive effects of Escherichia coli Nissle 1917 on dextran sulfate sodium-induced colitis in mice.
    Liang M; Zhang J; Yang Y; Xia Y; Liu L; Liu L; Wang Q; Gao X
    World J Microbiol Biotechnol; 2022 Nov; 39(1):8. PubMed ID: 36350434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outer Membrane Vesicles and Soluble Factors Released by Probiotic
    Alvarez CS; Badia J; Bosch M; Giménez R; Baldomà L
    Front Microbiol; 2016; 7():1981. PubMed ID: 28018313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity.
    Ukena SN; Singh A; Dringenberg U; Engelhardt R; Seidler U; Hansen W; Bleich A; Bruder D; Franzke A; Rogler G; Suerbaum S; Buer J; Gunzer F; Westendorf AM
    PLoS One; 2007 Dec; 2(12):e1308. PubMed ID: 18074031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair.
    Zyrek AA; Cichon C; Helms S; Enders C; Sonnenborn U; Schmidt MA
    Cell Microbiol; 2007 Mar; 9(3):804-16. PubMed ID: 17087734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor Colonization and Therapy by
    Gentschev I; Petrov I; Ye M; Kafuri Cifuentes L; Toews R; Cecil A; Oelschaeger TA; Szalay AA
    Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple effects of Escherichia coli Nissle 1917 on growth, biofilm formation, and inflammation cytokines profile of Clostridium perfringens type A strain CP4.
    Jiang Y; Kong Q; Roland KL; Wolf A; Curtiss R
    Pathog Dis; 2014 Apr; 70(3):390-400. PubMed ID: 24532573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Lactobacillus rhamnosus GG and Escherichia coli Nissle 1917 Cell-Free Supernatants on Modulation of Mucin and Cytokine Secretion on Human Intestinal Epithelial HT29-MTX Cells.
    Wan ML; Chen Z; Shah NP; El-Nezami H
    J Food Sci; 2018 Jul; 83(7):1999-2007. PubMed ID: 29863797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effects resulting from oral administration of
    Souza ELS; Campos CLV; Reis DC; Cassali GD; Generoso SV; Cardoso VN; Azevedo V; Medeiros JD; Fernandes GR; Nicoli JR; Martins FS
    Benef Microbes; 2020 Dec; 11(8):779-790. PubMed ID: 33191778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial MccM as the Major Microcin in
    Ma Y; Fu W; Hong B; Wang X; Jiang S; Wang J
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.